Back to search
Recurrent High Grade Meningioma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent High Grade Meningioma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent High Grade Meningioma trials you may qualify forStudy in children and adolescents of 177Lu DOTATATE (Lutathera®) combined with the PARP inhibitor olaparib for treatment of recurrent or relapsed solid tumours…
This study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATATE) in patients with progressive or recurrent High-Grade Central Nervous System (CNS)…
This multi-site, Phase 2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO100 (peri…
This phase I/II trial studies the side effects and best dose of nivolumab when given together with multi-fraction stereotactic radiosurgery and to see how well…
In the proposed trial, patients will be administered ribociclib prior to surgical resection of their tumor. Patients will be enrolled in time-intervals sequenti…